Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92,189,700
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
29,587,281
-
Shares change
-
+27,620,024
-
Total reported value, excl. options
-
$693,431,752
-
Value change
-
+$646,473,752
-
Number of buys
-
84
-
Price
-
$23.87
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q3 2021
86 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q3 2021.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,587,281 shares
of 92,189,700 outstanding shares and own 32.09% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (4,092,309 shares), FMR LLC (3,323,284 shares), FARALLON CAPITAL MANAGEMENT LLC (2,963,448 shares), Avidity Partners Management LP (2,474,067 shares), PICTET ASSET MANAGEMENT SA (1,964,707 shares), ALKEON CAPITAL MANAGEMENT LLC (1,246,625 shares), JANUS HENDERSON GROUP PLC (1,239,652 shares), BlackRock Inc. (1,181,540 shares), MAVERICK CAPITAL LTD (952,542 shares), and VANGUARD GROUP INC (936,400 shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.